glp 1 drugs blindness Ozempic Blindness: Should You Worry? The GLP-1 revolution: What UAB
Description
Tirzepatide, a newer GLP-1/GIP dual agonist, and retatrutide, a triple agonist still in trials, have pushed results even further, with average weight loss approaching 2025% of body weight
Purity varies from 62% to 100%, and actual peptide quantity in vials can deviate by up to 260% from the advertised amount
It not only successfully regulates blood sugar levels [1] but also reduces the appetite and, thereby, the weight of patients [2], especially in individuals with obesity and type 2 diabetes mellitus (T2DM)
In the USA, Mounjaro is FDA-approved for type 2 diabetes management
A: Shedding often begins 23 months after the main trigger (for example, the most dramatic weight-loss period) and can last several weeks to a few months
Oduori OS, Murao N, Shimomura K, Takahashi H, Zhang Q, Dou H, et al
